Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1986 Apr;203(4):352–359. doi: 10.1097/00000658-198604000-00003

Aggressive resection of metastatic disease in selected patients with malignant gastrinoma.

J A Norton, P H Sugarbaker, J L Doppman, R A Wesley, P N Maton, J D Gardner, R T Jensen
PMCID: PMC1251117  PMID: 2938550

Abstract

Fifteen patients with Zollinger-Ellison syndrome followed at the National Institutes of Health with extensive metastatic disease had an actuarial 5-year survival of 20%. Therefore, in 1982 a prospective study to examine the effect and feasibility of removing all gross tumor in selected patients with extensive metastatic disease was instituted. Five patients with extensive metastatic gastrinoma confined to the abdomen in whom imaging studies suggested the possibility of complete surgical resection were entered into this study and underwent attempted complete surgical resection and chemotherapy with streptozotocin, doxorubicin, and 5-fluorouracil. Median follow-up was 24 months. Surgical resection of all gastrinoma was possible in 4/5 patients attempted. In one patient in whom all gross disease could not be resected, the residual tumor progressed and the patient died 19 months after operation. All four patients with all disease resected appeared to benefit since all of them had a significant reduction in antisecretory medications and are enjoying normal activity and work. Three patients have had no detectable tumor on follow-up, and two of these patients are clinically and biochemically "cured" with normal fasting gastrin levels and negative provocative gastrin tests at 14 and 32 months. Therefore, aggressive resection of metastatic disease in selected patients with malignant gastrinoma is recommended.

Full text

PDF
352

Images in this article

356FIG. 2.
on p.356
356FIG. 3.
on p.356
357FIG. 4.
on p.357

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brennan M. F., Jensen R. T., Wesley R. A., Doppman J. L., McCarthy D. M. The role of surgery in patients with Zollinger-Ellison syndrome (ZES) managed medically. Ann Surg. 1982 Sep;196(3):239–245. doi: 10.1097/00000658-198209000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Collen M. J., Howard J. M., McArthur K. E., Raufman J. P., Cornelius M. J., Ciarleglio C. A., Gardner J. D., Jensen R. T. Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion. Ann Intern Med. 1984 Jan;100(1):52–58. doi: 10.7326/0003-4819-100-1-52. [DOI] [PubMed] [Google Scholar]
  3. Davis C. E., Jr, Vansant J. H. Zollinger-Ellison syndrome. Spontaneous regression of advanced intra-abdominal metastases with 20 year survival. Ann Surg. 1979 May;189(5):620–626. doi: 10.1097/00000658-197905000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Deveney C. W., Deveney K. E., Stark D., Moss A., Stein S., Way L. W. Resection of gastrinomas. Ann Surg. 1983 Oct;198(4):546–553. doi: 10.1097/00000658-198310000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Deveney C. W., Deveney K. S., Jaffe B. M., Jones R. S., Way L. W. Use of calcium and secretin in the diagnosis of gastrinoma (Zollinger-Ellison syndrome). Ann Intern Med. 1977 Dec;87(6):680–686. doi: 10.7326/0003-4819-87-6-680. [DOI] [PubMed] [Google Scholar]
  6. Deveney C. W., Deveney K. S., Way L. W. The Zollinger-Ellison syndrome--23 years later. Ann Surg. 1978 Sep;188(3):384–393. doi: 10.1097/00000658-197809000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Foster J. H. Survival after liver resection for secondary tumors. Am J Surg. 1978 Mar;135(3):389–394. doi: 10.1016/0002-9610(78)90072-7. [DOI] [PubMed] [Google Scholar]
  8. Fox P. S., Hofmann J. W., Wilson S. D., DeCosse J. J. Surgical management of the Zollinger-Ellison syndrome. Surg Clin North Am. 1974 Apr;54(2):395–407. doi: 10.1016/s0039-6109(16)40287-2. [DOI] [PubMed] [Google Scholar]
  9. Friesen S. R. Treatment of the Zollinger-Ellison syndrome. A 25 year assessment. Am J Surg. 1982 Mar;143(3):331–338. doi: 10.1016/0002-9610(82)90102-7. [DOI] [PubMed] [Google Scholar]
  10. Harmon J. W., Norton J. A., Collin M. J., Krudy A. G., Shawker T. H., Doppman J. L., d'Avis J., Jensen R. T. Removal of gastrinomas for control of Zollinger-Ellison syndrome. Ann Surg. 1984 Oct;200(4):396–404. doi: 10.1097/00000658-198410000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Howard J. M., Chremos A. N., Collen M. J., McArthur K. E., Cherner J. A., Maton P. N., Ciarleglio C. A., Cornelius M. J., Gardner J. D., Jensen R. T. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome. Gastroenterology. 1985 Apr;88(4):1026–1033. doi: 10.1016/s0016-5085(85)80024-x. [DOI] [PubMed] [Google Scholar]
  12. Jensen R. T., Gardner J. D., Raufman J. P., Pandol S. J., Doppman J. L., Collen M. J. Zollinger-Ellison syndrome: current concepts and management. Ann Intern Med. 1983 Jan;98(1):59–75. doi: 10.7326/0003-4819-98-1-59. [DOI] [PubMed] [Google Scholar]
  13. Lamers C. G., Van Tongeren J. H. Comparative study of the value of the calcium, secretin, and meal stimulated increase in serum gastrin to the diagnosis of the Zollinger-Ellison syndrome. Gut. 1977 Feb;18(2):128–135. doi: 10.1136/gut.18.2.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. McCarthy D. M. Report on the United States experience with cimetidine in Zollinger-Ellision syndrome and other hypersecretory states. Gastroenterology. 1978 Feb;74(2 Pt 2):453–458. [PubMed] [Google Scholar]
  15. McGuigan J. E., Wolfe M. M. Secretin injection test in the diagnosis of gastrinoma. Gastroenterology. 1980 Dec;79(6):1324–1331. [PubMed] [Google Scholar]
  16. Putnam J. B., Jr, Roth J. A., Wesley M. N., Johnston M. R., Rosenberg S. A. Survival following aggressive resection of pulmonary metastases from osteogenic sarcoma: analysis of prognostic factors. Ann Thorac Surg. 1983 Nov;36(5):516–523. doi: 10.1016/s0003-4975(10)60679-0. [DOI] [PubMed] [Google Scholar]
  17. Sugarbaker P. H., Vermess M., Doppman J. L., Miller D. L., Simon R. Improved detection of focal lesions with computerized tomographic examination of the liver using ethiodized oil emulsion (EOE-13) liver contrast. Cancer. 1984 Oct 15;54(8):1489–1495. doi: 10.1002/1097-0142(19841015)54:8<1489::aid-cncr2820540802>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  18. Thompson J. C., Reeder D. D., Villar H. V., Fender H. R. Natural history and experience with diagnosis and treatment of the Zollinger-Ellison syndrome. Surg Gynecol Obstet. 1975 May;140(5):721–739. [PubMed] [Google Scholar]
  19. Zollinger R. M., Ellison E. C., Fabri P. J., Johnson J., Sparks J., Carey L. C. Primary peptic ulcerations of the jejunum associated with islet cell tumors. Twenty-five-year appraisal. Ann Surg. 1980 Sep;192(3):422–430. doi: 10.1097/00000658-198009000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Zollinger R. M., Martin E. W., Jr, Carey L. C., Sparks J., Minton J. P. Observations on the postoperative tumor growth behavior of certain islet cell tumors. Ann Surg. 1976 Oct;184(4):525–530. doi: 10.1097/00000658-197610000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES